¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"myeloid sarcoma"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® sarcoma ÇÑ±Û À°Á¾
¼³¸í   
  »óÇǼ¼Æ÷¿¡¼­ ±â¿øÇÑ ¾Ç¼ºÁ¾¾çÀ» ¾ÏÁ¾(carcinoma)À̶ó°í Çϰí, Áß°£¿±Á¶Á÷¿¡¼­ ±â¿øÇÑ °áÇÕÁ¶Á÷, »À, ±ÙÀ° µî¿¡¼­ ±â¿øÇÑ ¾Ç¼º Á¾¾çÀ» À°Á¾À̶ó°í ÇÑ´Ù. ¿¹¸¦ µé¾î °ñÀ°Á¾(osteosarcoma)¶õ »ÀÀÇ ÀÏÂ÷ÀûÀΠ¾Ç¼º Á¾¾çÀÇ Çϳª·Î »ÀÁ¶Á÷À̳ª ¿¬°ñ Á¶Á÷À» ±Ù°£À¸·Î ÇÏ¿© ¾Ç¼º °áÇÕÁ¶Á÷ ±âÁú·Î ÀÌ·ç¾îÁ® Àִ °ÍÀ» ¸»ÇÔ. ±ÙÀ°À°Á¾, Áö¹æÀ°Á¾, ¼¶À¯À°Á¾µµ ¿©±â¿¡ ¼ÓÇÑ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agnogenic myeloid metaplasia
    ¿øÀκҸí°ñ¼öÈ­»ý
  • myeloid
    °ñ¼ö¸ð¾ç-, °ñ¼ö¼º
  • myeloid cell
    °ñ¼ö¼¼Æ÷
  • myeloid metaplasia
    °ñ¼öÈ­»ý
  • alveolar soft part sarcoma
    Æ÷»ó¿¬ºÎÀ°Á¾
  • clear cell sarcoma
    Åõ¸í¼¼Æ÷À°Á¾
  • Ewing¡¯s sarcoma
    À¯À×À°Á¾
  • endometrial stromal sarcoma
    Àڱ󻸷¹öÆÀÁúÀ°Á¾, Àڱ󻸷°£ÁúÀ°Á¾
  • epithelioid sarcoma
    »óÇǸð¾çÀ°Á¾
  • granulocytic sarcoma
    °ú¸³±¸À°Á¾
  • idiopathic hemorrhagic sarcoma
    Ư¹ßÃâÇ÷À°Á¾
  • Kaposi sarcoma
    Ä«Æ÷½ÃÀ°Á¾
  • osteoblastic sarcoma
    »À¸ð¼¼Æ÷À°Á¾, °ñ¸ð¼¼Æ÷À°Á¾
  • osteogenic sarcoma
    »ÀÀ°Á¾, °ñÀ°Á¾
  • osteoid sarcoma
    Dz»ÀÀ°Á¾, À¯°ñÀ°Á¾
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sarcoma
    À°Á¾
  • sarcoma botryoides
    Æ÷µµÀ°Á¾
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agnogenic myeloid metaplasia
    ¿øÀκҸí°ñ¼öÈ­»ý
  • myeloid cell
    (¢¡marrow cell) °ñ¼ö¼¼Æ÷
  • myeloid
    °ñ¼ö¸ð¾ç-
  • myeloid metaplasia
    °ñ¼öÈ­»ý
  • botryoides sarcoma
    Æ÷µµÀ°Á¾
  • clear cell sarcoma
    Åõ¸í¼¼Æ÷À°Á¾
  • endometrial stromal sarcoma
    Àڱ󻸷¹öÆÀÁúÀ°Á¾, Àڱ󻸷±âÁúÀ°Á¾
  • epithelioid sarcoma
    »óÇǸð¾çÀ°Á¾
  • granulocytic sarcoma
    °ú¸³¼¼Æ÷À°Á¾
  • idiopathic hemorrhagic sarcoma
    Ư¹ßÃâÇ÷À°Á¾
  • osteoblastic sarcoma
    »À¸ð¼¼Æ÷À°Á¾, °ñÇ÷¼ºÀ°Á¾
  • osteogenic sarcoma
    (¢¡osteosarcoma) »ÀÀ°Á¾, °ñÀ°Á¾
  • osteoid sarcoma
    À¯°ñÀ°Á¾, Dz»ÀÀ°Á¾
  • parosteal sarcoma
    »ÀÁÖÀ§À°Á¾, ¹æ°ñÀ°Á¾
  • periosteal sarcoma
    »À¸·À°Á¾, °ñ¸·À°Á¾
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agnogenic myeloid metaplasia
    ¿øÀκҸíÀÇ °ñ¼öÈ­»ýÁõ.
  • agnogenic(idiopathic) myeloid metaplasia
    ¿øÀκҸí(Ư¹ß¼º) °ñ¼öÈ­»ýÁõ(ê«ì×ÝÕÙ¥ ÍéâÐûùßæñø)
  • immature myeloid element
    ¹Ì¼÷°ñ¼ö¼º Ç÷__¡­ÍéâÐàõúìϹ).
  • immature myeloid element
    ¹Ì¼÷°ñ¼ö¼º Ç÷±¸(?Ë­ËàËÛÌ´Ë´).
  • Ewings sarcoma
    À¯À× À°Á¾.
  • Ewings sarcoma
    À¯À×À°Á¾.
  • Kaposi s sarcoma
    Ä«Æ÷½ÃÀ°Á¾.
  • Kaposis sarcoma
    Ä«Æ÷½ÃÀ°Á¾
  • Kaposis sarcoma (KS)
    Ä«Æ÷½ÃÀ°Á¾
  • Rous sarcoma virus
    ¶ó¿ì½º À°Á¾¹ÙÀÌ·¯½º
  • african kaposis sarcoma
    ¾ÆÇÁ¸®Ä« Ä«Æ÷Áö À°Á¾(¡­ë¿ðþ)
  • gastric sarcoma
    À§À°Á¾.
  • granulocytic sarcoma
    °ú¸³¼¼Æ÷ À°Á¾
  • idiopathic hemorrhagic sarcoma
    Ư¹ß¼º ÃâÇ÷¼º À°Á¾
  • polymorphous sarcoma
    ´ÙÇü(¼º) À°Á¾(Òýû¡(àõ) ë¿ðþ)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • agnogenic myeloid metaplasia
    ¿øÀκҸíÀÇ °ñ¼öÈ­»ýÁõ.
  • agnogenic(idiopathic) myeloid metaplasia
    ¿øÀκҸí(Ư¹ß¼º) °ñ¼öÈ­»ýÁõ(ê«ì×ÝÕÙ¥ ÍéâÐûùßæñø)
  • aleukemic myelosis=myelofibrosis with myeloid metaplasia
    ¹«¹éÇ÷¼º °ñ¼öÁõ
  • extramedullary myeloid cell tumor
    °ñ¼ö¿Ü°ñ¼ö¼¼Æ÷Á¾
  • immature myeloid element
    ¹Ì¼÷°ñ¼ö¼º Ç÷±¸(?Ë­ËàËÛÌ´Ë´).
  • immature myeloid element
    ¹Ì¼÷°ñ¼ö¼º Ç÷__¡­ÍéâÐàõúìϹ).
  • leukemia,myeloid, chronic
    ¸¸¼º °ñ¼ö¼º(Ø·àõ ÍéâÐàõ)
  • mature myeloid element
    ¼º¼÷°ñ¼ö¼º Ç÷±¸(?Ë­ËàËÛÌ´Ë´).
  • mature myeloid element
    ¼º¼÷°ñ¼ö¼º Ç÷±¸(¡­ÍéâÐàõúìϹ).
  • myelofibrosis with myeloid metaplasia
    °ñ¼ö¾çÈ­»ý(åÆûùßæ)°ñ¼ö¼¶À¯Áõ
  • myeloid
    °ñ¼ö¾ç(Ë­ËàËâ)ÀÇ.
  • myeloid antigen
    °ñ¼ö¾ç(ÍéâÐåÆ) Ç׿ø
  • myeloid cell
    °ñ¼ö¼¼Æ÷(¡­á¬øà).
  • myeloid cell
    °ñ¼ö¼¼Æ÷(?ËṴ̂).
  • myeloid element
    °ñ¼ö¼º Ç÷±¸(¡­àõúìϹ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Myeloid tissue
    °ñ¼öÁ¶Á÷
    [¿¾ ¿ë¾î] °ñ¼ö¾çÁ¶Á÷
  • Myeloid tissue
    °ñ¼öÁ¶Á÷ [»À¼ÓÁúÁ¶Á÷]
    [¿¾ ¿ë¾î] °ñ¼ö¾çÁ¶Á÷
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • avian sarcoma virus
    ±Ý·ùÀ°Á¾(ÐØ×¾ë¿ðþ) ¹ÙÀÌ·¯½º
  • Rous sarcoma
    ¶ó¿ì½º À°Á¾(ë¿ðþ)
  • Rous sarcoma virus
    ¶ó¿ì½º À°Á¾(ë¿ðþ) ¹ÙÀÌ·¯½º
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • immunoblastic sarcoma
    ¸é¿ª¾Æ¼¼Æ÷À°Á¾
  • Kaposi's sarcoma
    Ä«Æ÷½ÃÀ°Á¾
  • osteogenic sarcoma
    °ñ¿ø¼ºÀ°Á¾
  • parosteal sarcoma
    ¹æ°ñ¼ºÀ°Á¾
  • reticulum cell sarcoma
    ¼¼¸Á¼¼Æ÷À°Á¾
  • sarcoma
    À°Á¾
  • sarcoma botryoides
    º¸Å丮¿ÀÀ̵åÀ°Á¾
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MMM see 3-M [syndrome]; microsome-mediated mutagenesis; myelofibrosis with myeloid metaplasia; myeloscle...
MSV maximum sustained level of ventilation; mean scale value; mean spatial velocity; Moloney sarcoma vir...
AMM Agnogenic Myeloid Metaplasia
MF   1) Myelo-Fibrosis
    = Agnogenic Myeloid Metaplasia with Myelo-F...
ACML atypical chronic myeloid leukemia
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AML Acute Myeloid Leukaemia
AMM Agnogenic myeloid metaplasia
CML Chronic Myeloid Leukaemia
HL-60 Human myeloid leukemia cells
JCML Juvenile chronic myeloid leukaemia
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
  • C92.3
    Myeloid sarcoma
    °ñ¼ö¼º À°Á¾
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • agnogenic idiopathic myeloid metaplasia
    ¿øÀÎ ºÒ¸í Ư¹ß¼º °ñ¼ö È­»ýÁõ
  • immature myeloid precussor
    ¹Ì¼º¼÷ °ñ¼ö ¼¼Æ÷
  • myeloid
    °ñ¼ö¼º, °ñ¼öÁõ, °ñ¼ö¾çÀÇ
  • myeloid leukoses
    °ñ¼ö¼º ¹éÇ÷Áõ
  • African kaposis sarcoma
    ¾ÆÇÁ¸®Ä« Ä«Æ÷Áö À°Á¾
  • ameloblastic sarcoma
    ¹ý¶û¾Æ À°Á¾
  • clear cell sarcoma
    Åõ¸í ¼¼Æ÷ À°Á¾
  • endometrial stromal sarcoma
    Àڱ󻸷 ±âÁú À°Á¾
    Àú¾Ç¼º°ú °í¾Ç¼º Á¾¾çÀ¸·Î ±¸ºÐµÈ´Ù. Æò±Õ ¿¬·ÉÀº 42-53¼¼ÀÌ°í ¹Ý¼ö À̻󿡼­ Æó°æ±â ÀÌÀü¿¡ »ý±ä´Ù. ÁÖ Áõ»óÀº ÀÌ»ó ÀÚ±ÃÃâÇ÷, ÁÖ±âÀû ºÎÁ¤ Àڱà ÃâÇ÷ ¹× º¹ºÎ µ¿Åë µîÀÌ´Ù. ÈçÈ÷ ÀÚ±ÃÀÌ Ä¿Áö¹Ç·Î ÀÓ»óÀûÀ¸·Î ÀڱñÙÁ¾À¸·Î Áø´ÜµÉ ¶§°¡ ¸¹´Ù. À°¾ÈÀûÀ¸·Î Àú¾Ç¼ºÀº Àß °æ°èµÇÁö ¾Ê´Â Á¾±«°¡ ÁÖÀ§ÀÇ ±ÙÃþÀ¸·Î Ȳ°¥»öÀÇ ¼Ò°áÀýó·³ ħÀ±Çذ¡´Â °Í°ú ¶Ñ·ÇÇÑ Á¾±« Çü¼º ¾øÀÌ ÀڱñÙÃþÀÌ ¹Ì¸¸¼ºÀ¸·Î ºñÈĵǴ °Í, Á¾±«°¡ ±ÙÁ¾Ã³·³ ÁÖº¯ ºÎÀ§¿¡¼­ À¶±âµÇ¾î º¸ÀÌÁö¸¸ Àý´Ü¸éÀÌ È²°¥»öÀÌ°í ¿¬ÇÏ¿© ±ÙÁ¾°ú´Â ´Ù¸¥ °æ¿ìÀÇ ¼¼ °¡Áö ÇüŸ¦ ÃëÇÑ´Ù. °í¾Ç¼ºÀº ¿¬ÇÏ°í °í±â µ¢¾î¸® °°Àº ¿ëÁ¾¼º Á¾¾çÀ¸·Î Àڱó» °­ ¾ÈÀ¸·Î ÅÍÁ® ³ª¿Í ³»°­À» ä¿ì°Ô µÈ´Ù. ´Ù¹ß¼ºÀ̰í ÃâÇ÷°ú ±«»ç¸¦ ÈçÈ÷ º¸À̸ç Àڱñ٠ÃþÀ¸·Î ħÀ±ÇÑ´Ù.
  • Ewing's sarcoma
    Ewing À°Á¾, À¯À× À°Á¾
    °ñ¼ö·ÎºÎÅÍ ¹ß»ýÇÏ´Â ¾Ç¼º °ñ Á¾¾çÀÎ ³»ÇǼº °ñ¼öÁ¾À¸·Î¼­ ÅëÁõ, ¹ß¿­, ¹éÇ÷±¸ Áõ°¡ÁõÀ» µ¿¹ÝÇϸ鼭 Àå°ñ¿¡¼­ °¡Àå ÈçÇÏ´Ù.
  • Kaposi's sarcoma
    Ä«Æ÷½Ã À°Á¾, Kaposi À°Á¾
    ÇǺο¡¼­ ¹ß»ýÇϴ ƯÀÌÇÑ Ç÷°üÁ¾. ¼­¼­È÷ ÁøÇàµÇ´Â ¾Ç¼º °£¿± Á¶Á÷ Á¾¾çÀ¸·Î, 40-70¼¼ ³²ÀÚÀÇ ÇÏÁö¿¡¼­ È£¹ßÇÑ´Ù. ÀÓ»óÀûÀ¸·Î º´¼Ò´Â ÇǺΠ¾î´À ºÎÀ§¿¡¼­³ª ³ªÅ¸³¯ ¼ö ÀÖÀ¸³ª Ãʱ⿡´Â ´Ù¹ß¼ºÀÎ ÀÛÀº ÀûÀÚ»ö ¹Ý, ¶Ç´Â ±¸Áø°ú °áÀýÀÇ ÇüÅ·Π³ªÅ¸³­´Ù. °á±¹ È®´ëµÇ°í ¼­·Î À¶ÇÕÇÏ¿© ÀûÀÚ»ö Ç÷°ü Á¾¾çÀ» Çü¼ºÇÑ´Ù. ÈÄõ¼º ¸é¿ª °áÇÌÁõÀ̳ª ¾ÆÇÁ¸®Ä«Çü¿¡¼­´Â Àü½ÅÀûÀ¸·Î Àß ¹ß»ýÇÏ¸ç ¸ñ ¸²ÇÁÀý, Ÿ¾×¼±, ¾È¿Í¼± µéÀÌ º¸Åë óÀ½¿¡ ħ¹üµÇ°í, ³»ºÎ Àå±âÀÇ Ä§¹üÀº ´ë°³´Â ÇÕº´ÁõÀÌ´Ù.
  • oral kaposis sarcoma
    ±¸³» Ä«Æ÷½Ã ¾ÏÁ¾
  • osteoblastic sarcoma
    °ñÇü¼º¼º À°Á¾
  • osteogenic sarcoma
    °ñ¿ø¼º À°Á¾, °ñ À°Á¾
    »À¿¡¼­ ¹ß»ýÇÏ´Â °áÇÕÁ¶Á÷ÀÇ Á¾¾ç.
  • polymorphous sarcoma
    ´ÙÇü¼º À°Á¾
  • Rous sarcoma
    ¶ó¿ì½º À°Á¾
    1910³â F.P. ¶ó¿ì½º°¡ ¹ß°ßÇÑ À̽ÄÀÌ °¡´ÉÇÑ ´ßÀÇ ¹ÙÀÌ·¯½º ¾ÏÀ¸·Î ¾Ë·ÁÁø ¹æÃßÇü ¼¼Æ÷À°Á¾. À°Á¾ ¼¼Æ÷¸¦ ÇÔÀ¯ÇÏÁö ¾Ê´Â ¿©°ú¾×¿¡ ÀÇÇÏ¿© À̽ÄÀÌ °¡´ÉÇÏ´Ù´Â °ÍÀ» ¹ß°ßÇϰí, ±× ÈÄ¿¡ ±× ÀÎÀÚ°¡ ¹ÙÀÌ·¯½º¶ó´Â °ÍÀ» ¹ß°ßÇÔÀ¸·Î½á ³ëº§ »ý¸®, ÀÇÇлóÀ» ¹Þ¾Ò´Ù. ¿À´Ã³¯ ¹ß¾Ï ¹ÙÀÌ·¯½ºÀÇ ¿¬±¸¿¡ ³Î¸® ÀÌ¿ëµÇ°í ÀÖ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
myeloid sarcoma <tumour> A malignant tumour of immature myeloid cells, frequently subperiosteal, associated with or preceding granulocytic leukaemia.
See: chloroma.
Synonym: myeloid sarcoma.
(05 Mar 2000)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
acute myeloid leukaemia <haematology> A rapidly progressing cancer of the blood affecting immature cells of the bone marrow, usually of the white cell population. It is much more common in adults than in children.
Symptoms include fatigue, weight loss, fevers, weakness, pallor, bone pains, bleeding gums, nosebleeds, easy bruising, enlarged lymph nodes and joint pains.
Treatment includes chemotherapy and/or bone marrow transplant.
This leukaemia demonstrates granulocyte differentiation, eosinophilia and Auer rods and is associated with a reciprocal translocation between 8 and 21 (q22;q22), which is the most common translocation in acute myeloid leukaemia and is found more often in younger patients than in older patients. The oncogene involved in this translocation is AML1, which can be detected by Southern blot. Numerical abnormalities, particularly monosomy-7, trisomy-4, trisomy-8, trisomy-21, -Y, monosomy-7 and deletions of the long arms of chromosomes 5 and 7 are quite common in all acute myeloid leukaemia and not restricted to any one FAB classification. Many of these abnormalities are observed at diagnosis and at later stage disease, particularly after chemotherapy.
Prognosis is generally more favorable than in FAB-M2 patients showing no translocation, because the latter patients show better remission rates for longer periods of time. Immunophenotyping is useful in diagnosis and expression of one or more of the myeloid antigens CD13, CD14 or CD33 must be detected to make a diagnosis of acute myeloid leukaemia.
Acronym: AML
Incidence: 2,000 new cases per year in the UK.
Origin: Gr. Haima = blood
(07 Apr 1998)
agnogenic myeloid metaplasia A progressive disease of the bone marrow where neoplastic bone marrow stem cells lodge and grow in multiple sites outside the bone marrow. Typically, there is enlargement of the spleen and a gradual replacement of the bone marrow elements by fibrosis (scarring), progressive anaemia and variable changes in the number of white blood cells and platelets.
Diagnosis is by bone marrow biopsy. There is no definitive treatment for this disorder that has been shown to affect life span favorably.
Origin: Gr. Plassein = to form
(27 Sep 1997)
chronic myeloid leukaemia <haematology> A leukaemia which is initially slowly-progressing. There are approximately 650 new cases each year in the UK. It is characterised by the presence of large numbers of abnormal mature granulocytes, circulating in the blood.
Synonym: chronic granulocytic leukaemia.
Acronym: CML
Origin: Gr. Haima = blood
(12 Jan 1998)
myeloid Collective term for the nonlymphocyte groups of white blood cells. It includes cells from the granulocyte, monocyte and platelet lineages.
(13 Nov 1997)
myeloid cell <haematology, pathology> One of the two classes of marrow derived blood cells, includes megakaryocytes, erythrocyte precursors, mononuclear phagocytes and all the polymorphonuclear granulocytes. That all these are ultimately derived from one stem cell lineage is shown by the occurrence of the Philadelphia chromosome in these, but not lymphoid, cells. most authors tend, however, to restrict the term myeloid to mononuclear phagocytes and granulocytes and commonly distinguish a separate erythroid lineage.
(12 May 1997)
myeloid metaplasia A progressive disease of the bone marrow where neoplastic bone marrow stem cells lodge and grow in multiple sites outside the bone marrow. Typically, there is enlargement of the spleen and a gradual replacement of the bone marrow elements by fibrosis (scarring), progressive anaemia and variable changes in the number of white blood cells and platelets.
Diagnosis is by bone marrow biopsy. There is no definitive treatment for this disorder that has been shown to affect life span favorably.
Origin: Gr. Plassein = to form
(27 Sep 1997)
myeloid series The granulocytic and the erythrocytic series.
(05 Mar 2000)
myeloid tissue Bone marrow consisting of the developmental and adult stages of erythrocytes, granulocytes, and megakaryocytes in a stroma of reticular cells and fibres, with sinusoidal vascular channels.
(05 Mar 2000)
primary myeloid metaplasia Myeloid metaplasia occurring as the primary condition, often in association with myelofibrosis.
Synonym: agnogenic myeloid metaplasia.
(05 Mar 2000)
secondary myeloid metaplasia Myeloid metaplasia occurring in individuals with another disease.
Synonym: symptomatic myeloid metaplasia.
(05 Mar 2000)
symptomatic myeloid metaplasia Myeloid metaplasia occurring in individuals with another disease.
Synonym: symptomatic myeloid metaplasia.
(05 Mar 2000)
leukaemia, myeloid Form of leukaemia characterised by an uncontrolled proliferation of the myeloid lineage and their precursors in the bone marrow and other sites.
(12 Dec 1998)
alveolar soft part sarcoma <tumour> A malignant tumour formed of a reticular stroma of connective tissue enclosing aggregates of large round or polygonal cells; occurs in subcutaneous and fibromuscular tissues.
(05 Mar 2000)
ameloblastic sarcoma <tumour> A rapidly growing, painful, destructive, radiolucent odontogenic tumour that usually arises through malignant change in the mesenchymal component of a pre-existing ameloblastic fibroma.
Synonym: ameloblastic sarcoma.
(05 Mar 2000)
angiolithic sarcoma <tumour> A firm cellular neoplasm derived from fibrous tissue of the meninges, choroid plexus, and certain other structures associated with the brain, characterised by the formation of multiple, discrete, concentrically laminated, calcareous bodies (psammoma bodies); most of these neoplasms are histologically benign, but may lead to severe symptoms as a result of compressing the brain.
Synonym: angiolithic sarcoma, sand tumour, Virchow's psammoma.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sarcoma
    À°Á¾
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á